Science AI Journal
Medicine · Research topic

Open research questions in Platelet Disorders and Treatments

27 unresolved questions extracted from the limitations and future-work sections of 300 Platelet Disorders and Treatments papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • Due to conflicting data in the published literature on antibody clonality in heparin-induced thrombocytopenia (HIT), we evaluated clonality and abundance of anti-PF4 antibodies in HIT, including investigating whether an MGUS, if present in HIT, represents the causative anti-PF4 antibody.

    Anti-Platelet Factor 4 Antibody Clonal Heterogeneity and MGUS Status in HIT · 2026 · DOI

  • Thrombopoietin receptor agonists (TPO-RAs) such as eltrombopag have emerged as promising agents in refractory SAA, though evidence of their safety in pregnancy remains scarce.

    Use of Thrombopoietin Receptor Agonists in Severe Aplastic Anemia During Pregnancy: A Case Report · 2026 · DOI

  • The authors would like to thank the clinical staff for their assistance in performing the study. Limitations of this study include its retrospective design, as data capture depended on clinicians’ documentation and clinical judgment, despite predefined study definitions. Standardization was further limited by changes in disease definitions over the study period, and some older cases lacked complete data. As a single- center study, our findings may also reflect local referral patterns and practice characteristics, which may limit generalizability. Conflict of interest The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

    Fifteen years of pediatric immune thrombocytopenia in a national cohort: chronicity, diagnostic challenges, and treatment patterns—single center experience · 2026 · DOI

  • Several limitations of this study should be acknowledged. First, the clinical cohort comprised a relatively small num- ber of subjects (24 CAD patients and 24 controls), and there were some incomparable confounding factors between the groups (e.g. hypertension, hyperlipidemia, and smoking). These factors reduced statistical power and increased the risk of both type I and type II errors. The cross-sectional design precluded any causal inference regarding the relationship between FVII levels, monocytes activation, and inflamma- tory factors. The high correlations between coagulation and inflammation, observed across the combined cohort, might partly reflect a clustering effect (separation of control group vs. CAD group) rather than a genuine mechanistic link. There- fore, our clinical findings should be considered exploratory, and independent validation in larger, well-matched cohorts is required. Third, the in vitro experiments used a suprapatho- logical concentration of FVIIa (100 nM), which was consid- erably higher than the levels observed in patients with CAD. This raised concerns about the pathophysiological relevance of the observed effects, as supraphysiological stimuli might exaggerate cellular responses. Moreover, NF-κB activation was evaluated only by total protein expression, we did not assess phosphorylation status or nuclear translocation, which would provide more direct evidence of pathway activation. Future studies should use disease-relevant concentrations of FVIIa and incorporate more rigorous experimental valida- tion to confirm the mechanistic link. Collectively, despite these limitations, the study provides interesting and poten- tially impactful insights into the coagulation-inflammatory mechanisms contributing to residual inflammation in CAD.

    Crosstalk between the monocytes and coagulation factor VⅡa aggravates the inflammation in patients with CAD · 2026 · DOI

  • Conflict of interest Platelets sit at the immune-coagulation-vascular interface and provide a distinctive entry point for nanomedicine engineering. Over the past decade, platelet functions have been modularized into synthetic platforms. The central value of platelet biomimicry is selective, controllable reconstruction that decouples efficacy from systemic risk within the structure-membrane-function-gating design space. Across indications, performance gains most often arise from interface state recognition and programmable control at immune- coagulation coupling nodes rather than unconditional procoagulant or aggregation enhancement. Platelet-inspired systems recurrently The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

    Engineering design of platelet-mimicking therapeutic systems: multilevel biomimicry, gating strategies, and translational boundaries · 2026 · DOI

  • In the future, the use of a standardized classification system, together with a detailed reporting on APC protocol parameters is warranted to make study outcomes comparable.

    Differences between first‐ and second‐generation autologous platelet concentrates · 2024 · DOI

  • Although in general PRP therapy is considered a promising method for treatment of tissue injuries, the lack of standardized preparation procedures and ways of PRP application raises numerous questions and controversies.

    Autologous platelet-rich plasma therapy — a promising method for tissue repair/ /regeneration in many medical fields · 2020 · DOI

  • Although some matters still remain unclear, it can be said that MPV, especially in a scoring system, may be a cost-effective and useful marker for monitoring and predicting outcomes in patients with some infectious diseases in…

    Could mean platelet volume be a useful marker for infectious diseases? a review of literature · 2016 · DOI

  • While childhood ITP is usually acute, self-limiting and generally seasonal in nature, ITP in adults is usually chronic; its relation with seasons has not been studied.

    Seasonal Association of Immune Thrombocytopenia in Adults · 2015 · DOI

  • Systematic platelet-function studies in patients with ASMD are currently lacking.

    Potential Mechanisms of Platelet Dysfunction and Bleeding in Acid Sphingomyelinase Deficiency · 2026 · DOI

  • However, few studies have evaluated non-criteria antiphospholipid antibodies in the acute phase of VTE.

    IgA anti-β2-glycoprotein I as an independent risk factor in acute venous thromboembolism · 2026 · DOI

  • Despite extensive experimental characterization of shear-induced platelet aggregation, a unified theoretical framework that maps hemodynamic forcing onto clot nucleation is lacking.

    Force-Gated Thrombosis (FGT): A Non-Equilibrium Mechanical Theory of Shear-Induced Blood Clot Initiation · 2026 · DOI

  • Furthermore, in this subset of patients, there are open issues regarding the delivery mode, to preserve the newborn who could be affected by the same bleeding disorder.

    Rare inherited autosomal bleeding disorders in women: sex-related bleeding, pregnancy and delivery. A narrative review. · 2026 · DOI

  • Taken together, the available structural and functional evidence may help interpret response variability and the clinical observation of benefit after switching agents, although the underlying mechanistic links remain to be established.

    MPL receptor dimerization and the thrombopoietin pathway in primary immune thrombocytopenia: from molecular mechanisms to targeted therapies · 2026 · DOI

Most-cited papers in Platelet Disorders and Treatments

Most recent work

Find a gap in your own Platelet Disorders and Treatments sub-topic

This page shows what the Platelet Disorders and Treatments literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Medicine

Substance Abuse Treatment and Outcomes
989 open questions
Artificial Intelligence in Healthcare and Education
607 open questions
Attention Deficit Hyperactivity Disorder
448 open questions
Physical Activity and Health
436 open questions
Smoking Behavior and Cessation
402 open questions
Innovations in Medical Education
364 open questions
Dementia and Cognitive Impairment Research
363 open questions
HIV/AIDS Research and Interventions
342 open questions
27 open questions have been extracted from the limitations and future-work passages of 300 Platelet Disorders and Treatments papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.